Pharmacy Podcast Network

Participants and Roles:         Sheila Arquette, President & CEO, NASP, Host/Interviewer                            Purpose: Discuss how implementing risk-based care benefits patients and can improve their adherence rates Ashleigh Burdette, MSN, RN, is the Sr. Director of Clinical Innovation with Biologics by McKesson. Ashleigh has been a Registered Nurse for nearly 15 years and holds a Master of Science in Nursing with a specialization in leadership and administration. She began her nursing career as an oncology nurse working in both bone marrow transplant and an outpatient clinic. In 2015, she joined Optum/United Health Group to focus on oncology patient support, utilization review, and clinical case management. In 2017, she joined Cardinal Health’s hub business and had the opportunity to lead both clinical operations and account management. Ashleigh joined Biologics by McKesson in 2020 to lead cross-functional collaboration to create customized patient management solutions that support the holistic needs of patients. ·            What is risked-based care, and how does it differ from “standardized care”? ·            What’s the methodology behind risked-based care? ·            Is the nurse-patient connection important? Why or why not? ·            What are some outcomes you’ve seen with this type of personalized level of care and support? ·            If someone wanted to implement this type of tailored support in their care setting, what are some of the essential components to keep in mind? Contact the NASP: https://naspnet.org/about Learn more about your ad choices. Visit megaphone.fm/adchoices

Where Pharmacists Go for Medical Information Due to the advancement of technology, healthcare professionals have access to a wealth of medical information in just a few strokes of their keyboard. Thinking of the quantity of resources available brings up the question, what sources of information are actually being used to inform treatment decisions? Join us in this episode where Patrick Reilly, PA, CEO phactMI and guest speakers John Jones, MBA, Director of Technology phactMI and Evelyn Hermes-DeSantis, PharmD, BCPS, Director, Research and Publications, phactMI/ Professor Emerita, Rutgers, The State University of New Jersey discuss the most common sources of medical information and the role of manufacturers in providing scientifically accurate information. This is the second episode in a series of three podcasts. If you have not listened to our first episode, check it out with the link below: ●           phactMI: Collaborate, Elevate, Enhance Patient Care: https://pharmacypodcast.com/2021/12/11/phactmi-podcast-series/   Learn more about phactMI at www.phactMI.org/about/ Follow phactMI on LinkedIn, Facebook, and Twitter Learn more about your ad choices. Visit megaphone.fm/adchoices

Educational Objectives ·            Recognize best practices for managing adverse effects associated with immune checkpoint inhibitor (ICI)-targeted therapy combinations   Faculty: Jacob K. Kettle, PharmD, BCOP Pharmacy Manager Ellis Fischel Cancer Center Department of Pharmacy University of Missouri Health Care Columbia, Missouri   Faculty, has the following financial relationships with commercial interests to disclose: Jacob Kettle, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose: Speakers Bureau: Genentech, Merck, Amgen, Lilly, DSI Consultant: Pfizer, Lilly Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hours (0.075 CEU) under the ACPE universal activity number 0290-0000-21-438-H01-P. The activity is available for CE credit through December 17, 2022. This activity is supported by educational grants from Eisai Inc and Exelixis, Inc. Learn more about your ad choices. Visit megaphone.fm/adchoices

Educational Objectives ·             Describe the role of immune checkpoint inhibitor (ICI)-targeted therapy combinations across malignancies ·             Recall knowledge of ICI-targeted therapy combinations to treatment selection in patients with cancer   Faculty: Jacob K. Kettle, PharmD, BCOP Pharmacy Manager Ellis Fischel Cancer Center Department of Pharmacy University of Missouri Health Care Columbia, Missouri Faculty, has the following financial relationships with commercial interests to disclose: Jacob Kettle, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose: Speakers Bureau: Genentech, Merck, Amgen, Lilly, DSI Consultant: Pfizer, Lilly Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-21-437-H01-P. The activity is available for CE credit through December 17, 2022. This activity is supported by educational grants from Eisai Inc and Exelixis, Inc. Learn more about your ad choices. Visit megaphone.fm/adchoices

Introduction As the safety of compounding practices comes under renewed scrutiny from authoritative bodies, more attention is being paid to assistive and robotic technologies. Learn how a stepped approach to adopting compounding technology can lead to safer, more efficient, and cost effective compounding operations. Participants Host: Ken Perez, Vice President, Healthcare Policy and Government Affairs, Omnicell, Inc. Guest Expert: Kevin N. Hansen, PharmD, MS, BCPS, BCSCP, Assistant Director of Pharmacy, Moses H. Cone Memorial Hospital Learn more about your ad choices. Visit megaphone.fm/adchoices

On this episode of the PAIN POD, Mark Pain Guy Garofoli will chat with Dr. David Brushwood, a world-renowned pharmacy law expert, about all things pain management, controlled substances, drug diversion, and pharmacy law. You may be sitting down listening, but it turns out you’ll only be using the edge of the seat! Corresponding legal responsibility, check. Professional conversations between prescribers and dispensers alike, check. DEA Red Flags, check. An attempted prescription from a zoo, check, wait, what? Yes, check. You name it, if it’s pharmacy law and pain management related, it’s discussed, right here, right now, on the Pain Pod. Come one, come all, to the Pain Pod!!! DEA Red Flags Info Prescribers Cash only patients and/or no acceptance of worker’s compensation or insurance Prescribing of the same combination of highly-abused medications Prescribing the same (high) quantities of pain drugs to most/every patient High number of prescriptions issued per day Geographically out-of-area patient population Dispensers High percentage controlled to non-controlled medications High volumes of controlled substances generally Same Medication(s)/Quantities prescribed by the same prescriber for many patients Large geographical distances between pharmacy, prescriber(s), and patient Multiple patients with the same last name or address Sequential prescription #s for highly diverted drugs from the same prescriber Patients receiving controlled substances from multiple prescribers Patients seeking early prescription refills paying out-of-pocket NABP ”Red Flags” Video https://nabp.pharmacy/initiatives/awarxe/pharmacist-resources/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Bob Graul is a consultant providing Business Development Services for First Financial Bank’s Professional Services Division and has Graul Consulting – Small Business Consulting. Mr. Graul hosts Pharmacy Insiders on the Pharmacy Podcast Network. Mr. Graul was Managing Director for the Professional Services Division of First Financial Bank which closed $50M in SBA loans annually. As National Vice President – RxOwnership for McKesson Corp from 2010 to 2015 Mr. Graul developed and launched RxOwnership and built it into a $1 billion program. Mr. Graul was President and CEO of Rancho Santa Fe Health Mart Pharmacy from 1985 to 2008 guiding it from $700K to $6M annually. He also served as CFO for OBJ, Inc. Graul was a consultant for retail pharmacies and McKesson Corp with responsibility for the RxOwnership program from 2008 to 2010. Additionally, he has served on several Boards and held voluntary consulting positions within the pharmaceutical industry. He has broad experience in the banking, retail drug, ownership transfer and managed care industries. Graul received the Outstanding Alumni Award from National University in 1997. He was named Pharmacist of the Year in 2005 by the San Diego County Pharmacist Association. Graul was awarded the Innovative Pharmacist of the year in February 2007 by the California Pharmacists Association. He was appointed to the California State Board of Pharmacy by Governor Schwarzenegger in February of 2007 and served for one term on the Board. Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharmacy Times Continuing Education™ (PTCE) provides industry-leading pharmacy CE to retail, oncology, managed care, specialty, and health-system pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education. Podcast 1: Waldenström Macroglobulinemia and Treatment Advancements with the Use of BTK Inhibitors Educational Objectives ·             Outline the pathophysiology of Waldenström macroglobulinemia (WM) and its connection to use of new and emerging drug therapies ·             Review clinical guidelines and treatment selection in patients with WM Faculty: Victoria Nachar, PharmD, BCOP Clinical Pharmacist Specialist, Ambulatory Hematology Oncology University of Michigan Rogel Cancer Center Clinical Assistant Professor University of Michigan College of Pharmacy Ann Arbor, Michigan   Faculty has no financial relationships with commercial interests to disclose. Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-21-441-H01-P. The activity is available for CE credit through June 13, 2022.  This activity is supported by educational grants from Pharmacyclics LLC., an AbbVie Company and Janssen Biotech, Inc; and BeiGene, Ltd. Learn more about your ad choices. Visit megaphone.fm/adchoices

Listen in as host Monique Whitney speaks with special guests Dr. Benjamin Jolley and Deborah Keaveny about the vertical integration of healthcare, how it applies to antitrust, and possible steps state and federal governments can take to begin to combat the issue for pharmacies and their patients. Host:  Monique Whitney, PUTT Executive Director Special Guests:  Dr. Benjamin Jolley, PharmD Pharmacist, Pharmacy Consultant, Blogger  Deborah Keaveny, RPh Pharmacist, Pharmacy Owner, PUTT Board Member Learn more about your ad choices. Visit megaphone.fm/adchoices

Pharmacy pioneer Bruce Kneeland selects 4 road trip pharmacies The trip, dubbed “Four Savvy Southern Pharmacies,” will include on-site visits and interviews with the owners of pharmacies in Texas, Arkansas, Tennessee and South Carolina. Summary written by Sandra Levy Independent pharmacy veteran Bruce Kneeland is once again hitting the open road on an extensive pharmacy road trip. This year's trip, dubbed “Four Savvy Southern Pharmacies,” will include on-site visits and interviews with the owners of pharmacies in four southern states: Texas, Arkansas, Tennessee and South Carolina.  Liberty Software, is sponsoring the trip.  [Read more: Pharmacy pioneer Bruce Kneeland selects 8 road trip pharmacies] The key takeaway will be the production and distribution of a white paper that Kneeland will produce. The document will outline, in a step-by-step manner, the management tools and marketing techniques the four pharmacies use to successfully implement one or more of the enhanced care services their pharmacies provide.    Kneeland will look at how these four pharmacies chose a specific enhanced care service to provide and how they got their staff to buy into providing the new service. He also will look for ways the pharmacies use features in their Liberty Software system to support these new services. One of Liberty’s newest features is an appointment scheduler with features that help them manage their immunization program, interact with state immunization registries, automate billing procedures and auto-populate eCare plans.  [Read more: CPESN USA taps Bruce Kneeland to support local networks] The pharmacies Kneeland will visit provide a cross-section of independent pharmacies. One is in a major metropolitan area, another in a suburban location and two are in rural towns. Two are clinically focused and the others have more traditional front-ends. One even has an old fashion soda fountain.    The four pharmacies to be visited are Flower Mound Pharmacy in Flower Mound, Texas; Caldwell Pharmacy in Wynne, Ark.; Kirby Whitten Pharmacy in Bartlett, Tenn.; and Roche Pharmacy in Whitmire, S.C.  Kneeland noted that the white paper will be designed to provide pharmacy owners with a road map that will outline specific steps pharmacy owners can take to replicate the success of the four pharmacies he visits on the trip. When completed, the white paper will be made available, free of charge, to any pharmacy owner requesting it from Liberty Software Learn more about your ad choices. Visit megaphone.fm/adchoices